Liposomes are now considered the most commonly used nanocarriers for various potentially
active hydrophobic and hydrophilic molecules due to their high biocompatibility …

Liposomes are nano-sized spherical vesicles composed of an aqueous core surrounded by
one (or more) phospholipid bilayer shells. Owing to their high biocompatibility, chemical …

Liposomes are essentially a subtype of nanoparticles comprising a hydrophobic tail and a
hydrophilic head constituting a phospholipid membrane. The spherical or multilayered …

Since their first discovery in the 1960s by Alec Bangham, liposomes have been shown to be
effective drug delivery systems for treating various cancers. Several liposome-based …

Liposome possesses a great number of advantages and therefore they can be used for a
variety of applications. Among other things, they can serve as useful drug carriers in …

Protein-based therapeutics are an attractive alternative to established therapeutic
approaches and represent one of the fastest growing families of drugs. While many of these …

Lipid vesicles can provide a cost-effective enhancement of skin drug absorption when
vesicle production process is optimised. It is an important challenge to design the ideal …

Freeze-drying is the most widespread method to preserve protein drugs and vaccines in a
dry form facilitating their storage and transportation without the laborious and expensive cold …

In the last decades, pharmaceutical interested researches aimed to develop novel and
innovative drug delivery techniques in the medical and pharmaceutical fields. Recently …

Messenger RNA (mRNA) lipid nanoparticles (LNPs) have emerged at the forefront during
the COVID-19 vaccination campaign. Despite their tremendous success, mRNA vaccines …